Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Starting Materials Directive To Receive Parliamentary Review In 2000

Executive Summary

A draft proposal on good manufacturing practices for starting materials and inspection of manufacturers will likely be submitted to the European Parliament and Council by the European Commission in 2000, the EU's Pharmaceutical Committee suggested at its most recent meeting.

You may also be interested in...



P&U Detrol Campaign Finds Detractors in U.K Consumer Group

The U.K.' s Consumer Association has asked the Blair government to review its policies on Rx advertising in the wake of the disease awareness TV campaign for Pharmacia & Upjohn's overactive bladder therapy Detrol/Detrusitol (tolterodine), launched Sept. 1.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034328

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel